怀孕期间患有的妇女:当前指导方针的系统审查
Zhu Liu1, Qiulei Hong1, Luyan Huang1
1Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Epilepsy & behavior : E&B
|August 28, 2025
概括
这项审查发现对孕妇治疗的指导方针有限且不一致. 需要更多的研究和大规模的注册表以更好地基于证据的建议.
科学领域:
- 神经学
- 妇产科
- 临床指南的制定
背景情况:
- 会影响生育年龄的女性.
- 在怀孕期间治疗对于母亲和胎儿来说都是独特的挑战.
研究的目的:
- 系统评估现有临床指南的质量,用于治疗患有的孕妇.
- 将这些指南中的关键建议进行比较.
主要方法:
- 对临床实践指南和专家共识陈述的系统审查.
- 使用研究和评估指南评估II (AGREE II) 工具进行质量评估.
- 对提取的核心信息进行比较分析.
主要成果:
- 确定了14条指导方针,其中大部分具有良好的范围和清晰度,但证据基础较弱.
- 关于怀孕前咨询,叶酸,阴道分娩,母乳养和避免使用氨酸的一致建议.
- 在抗发作药物 (ASM) 选择,药物监测和叶酸剂量方面发现差异;在较新的ASM和疼痛管理方面存在差异.
结论:
- 指导方针的变化凸显了证据不足和方法严格的需要.
- 需要加强基于证据的建议.
- 为了改进未来的指导方针, 大规模的潜在怀孕登记处至关重要.
相关概念视频
Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274
Antiepileptic Drugs: GABAergic Pathway Potentiators
635
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
635
Electroconvulsive Therapy
182
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
182
Seizures: Classification
584
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
584
Antiepileptic Drugs: Calcium Channel Blockers
608
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
608


